马斯克Neuralink 10月试验新脑机接口，助失语者“意念说话”

Core Insights - Neuralink, founded by Elon Musk, plans to launch a new trial in October aimed at helping aphasia patients convert thoughts into text or speech directly from their brains [1][2] - The system captures brain signals when a person "wants to speak," enabling direct conversion from brain activity to sound [1] - The device has received "Breakthrough Device" designation from the FDA, which expedites the approval process for innovative medical devices that may significantly improve treatment for serious conditions [1] Company Developments - Neuralink is set to begin human trials in 2024 after previously being denied by the FDA in 2022 due to safety concerns; the company has since improved its design to meet regulatory requirements [2] - Currently, 12 subjects have implanted chips, with a total usage time exceeding 15,000 hours, providing substantial real-world data [2] Technological Applications - The brain-machine interface was initially designed to assist patients with spinal cord injuries and other motor impairments in regaining some functionality [5] - The first subject has demonstrated the ability to play video games, browse the internet, post on social media, and control a laptop cursor using only their thoughts [5] - The expansion of this technology into the field of language disorders could offer new communication methods for patients suffering from conditions like stroke and ALS [5]